Prognostic significance of palliative gastrectomy in incurable advanced gastric cancer: a retrospective cohort study and meta-analysis

被引:10
|
作者
Zheng, C. [1 ]
Gao, Z-M [1 ]
Huang, H-B [1 ]
Li, K. [1 ]
Liu, X-F [1 ]
机构
[1] China Med Univ, Dept Surg Oncol & Gen Surg, Affiliated Hosp, Shenyang, Peoples R China
关键词
Gastric cancer; Incurable; Palliative gastrectomy; Metastasis; NON-CURATIVE GASTRECTOMY; PLUS CHEMOTHERAPY; SURVIVAL BENEFIT; RESECTION; SURGERY; MORTALITY; IMPACT; RATES; AGE;
D O I
10.26355/eurrev_202103_25262
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: There is controversy regarding the role of palliative gastrectomy in patients with incurable advanced gastric cancer requiring surgical intervention. The present retrospective cohort study and meta-analysis aimed to determine whether palliative gastrectomy plus chemotherapy can prolong the survival of patients with incurable advanced gastric cancer requiring surgical intervention. PATIENTS AND METHODS: The data from 153 patients diagnosed with incurable advanced gastric cancer requiring surgical intervention at our institute between January 2000 and December 2012 were retrospectively reviewed. We analyzed the value of palliative gastrectomy and identified the potential prognostic factors. We also conducted a meta-analysis of 10 studies to validate our results. RESULTS: Multivariate analysis indicated that palliative gastrectomy was a favorable independent prognostic factor for prolonged overall survival in incurable advanced gastric cancer patients requiring surgical intervention (p=0.029). The median survival of patients who underwent palliative gastrectomy plus chemotherapy was significantly longer than that of those who underwent non-resection surgery plus chemotherapy (12 months vs. 9 months, p=0.020). The patients in the non-resection surgery plus chemotherapy group exhibited significantly shorter overall survival than those in the D1+ lymphadenectomy group, D2 lymphadenectomy group, or distal gastrectomy group (p=0.021, p= 0.007, and p=0.006, respectively). Our meta-analysis revealed that gastrectomy plus chemotherapy improved long-term survival in incurable advanced gastric cancer patients (hazard ratio (HR): 0.48; 95% confidence interval (CI): 0.35-0.67; p<0.001). CONCLUSIONS: Palliative gastrectomy plus chemotherapy may improve overall patient survival compared with non-resection operations plus chemotherapy in incurable advanced gastric cancer patients requiring surgical intervention.
引用
收藏
页码:2299 / 2312
页数:14
相关论文
共 50 条
  • [21] Clinicopathological significance and prognostic role of microvessel density in gastric cancer: A meta-analysis
    Hong, Won Gi
    Ko, Young San
    Pyo, Jung-Soo
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (12) : 1459 - 1463
  • [22] Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis
    Long, Bo
    Yu, Zeyuan
    Zhou, Huinian
    Ma, Zhijian
    Ren, Yanxian
    Zhan, Hao
    Li, Long
    Cao, Hongtai
    Jiao, Zuoyi
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 56 : 242 - 249
  • [23] Survival benefits of gastrectomy in patients with metastatic gastric cancer: A meta-analysis
    Chen, Lifan
    Chen, Yu
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024, : 9 - 23
  • [24] Prognostic significance of tumor deposits in radically resected gastric cancer: a retrospective study of a cohort of 1915 Chinese individuals
    Zhou, Menglong
    Yang, Wang
    Zou, Wei
    Yang, Jianing
    Zhou, Changming
    Zhang, Zhiyuan
    Wang, Yaqi
    Zhang, Jing
    Wang, Yan
    Li, Guichao
    Zhang, Zhen
    Xia, Fan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [25] Body mass index and skeletal muscle index are useful prognostic factors for overall survival after gastrectomy for gastric cancer Retrospective cohort study
    Kim, Eun Young
    Jun, Kyong Hwa
    Kim, Shinn Young
    Chin, Hyung Min
    MEDICINE, 2020, 99 (47) : E23363
  • [26] Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study
    Hasegawa, Shinichi
    Kunisaki, Chikara
    Ono, Hidetaka
    Oshima, Takashi
    Fujii, Shoichi
    Taguri, Masataka
    Morita, Satoshi
    Sato, Tsutomu
    Yamada, Roppei
    Yukawa, Norio
    Rino, Yasushi
    Masuda, Munetaka
    GASTRIC CANCER, 2013, 16 (03) : 383 - 388
  • [27] Laparoscopic versus open D2 gastrectomy for advanced gastric cancer: a retrospective cohort study
    Shinohara, Toshihiko
    Satoh, Seiji
    Kanaya, Seiichiro
    Ishida, Yoshinori
    Taniguchi, Keizo
    Isogaki, Jun
    Inaba, Kazuki
    Yanaga, Katsuhiko
    Uyama, Ichiro
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2013, 27 (01): : 286 - 294
  • [28] Surgical and Survival Outcome Following Truly Palliative Gastrectomy in Patients with Incurable Gastric Cancer
    Tokunaga, Masanori
    Makuuchi, Rie
    Miki, Yuichiro
    Tanizawa, Yutaka
    Bando, Etsuro
    Kawamura, Taiichi
    Terashima, Masanori
    WORLD JOURNAL OF SURGERY, 2016, 40 (05) : 1172 - 1177
  • [29] Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: A meta-analysis
    Ma, Jian-ying
    Liu, Qin
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 50 : 67 - 71
  • [30] Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study
    Shinichi Hasegawa
    Chikara Kunisaki
    Hidetaka Ono
    Takashi Oshima
    Shoichi Fujii
    Masataka Taguri
    Satoshi Morita
    Tsutomu Sato
    Roppei Yamada
    Norio Yukawa
    Yasushi Rino
    Munetaka Masuda
    Gastric Cancer, 2013, 16 : 383 - 388